Stocks
JPMorgan Chase Cuts Oculis Target Price to $20.00
Financial analysts at JPMorgan Chase & Co. have cut their target price for Oculis (NASDAQ:OCS) from $23.00 to $20.00, citing a potential upside of 55.35% from the stock's previous close.
The brokerage currently maintains an 'overweight' rating on the stock.
This adjustment was made in a report issued by JPMorgan Chase & Co. on Friday and is based on market analysis and predictions.
Oculis has also received updates from other analysts, with Needham & Company LLC reducing their price objective to $38.00, Guggenheim cutting theirs to $45.00, and Stifel Nicolaus lowering theirs to $40.00.